Buy Orgenesis Stock | ORGS Stock Price & Latest News | Public.com
ORGS

Orgenesis

$0.00 (0.00%)Today
    Small Market Cap
    View Orgenesis (ORGS) stock trends here

    About ORGS

    Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry. It operates through the Contract Development and Manufacturing Organization (CDMO) and Point-Of-...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.42
    -0.84
    -1.27
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.10

    Actual EPS
    Q4 2020

    Stats

    Market Cap$169,09M
    Volume21,16k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$8.20
    1 Year Low$2.76
    Open$7.10
    High$7.15
    Low$6.95

    Buy any stock with any amount of money.

    Download the App
    Download the app